| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/09/2008 | EP1521831B1 Transgenic animal expressing truncated alzheimer's tau protein |
| 04/09/2008 | EP1442114B1 Bacterium causing poultry disease and vaccine derived therefrom |
| 04/09/2008 | EP1420032B1 Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody |
| 04/09/2008 | EP1394261A4 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 04/09/2008 | EP1240333B1 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 04/09/2008 | EP1228095B1 Modified gp100 and uses thereof |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1027440B1 Inhibitor protein of the wnt signal pathway |
| 04/09/2008 | EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof |
| 04/09/2008 | CN101160528A Use of il-17f in diagnosis and therapy of airway inflammation |
| 04/09/2008 | CN101160402A Cancer specific antibody and cell surface proteins |
| 04/09/2008 | CN101160322A Molecules and chimeric molecules thereof |
| 04/09/2008 | CN101160321A Q3 sparc deletion mutant and uses thereof |
| 04/09/2008 | CN101160137A Use of CD 25antibody in immunity treatment |
| 04/09/2008 | CN101157907A Recombinant salmonella choleraesuis strain for expression of pig origin bordetella bronchisepatica fhaB and prn gene segment, bacterin and uses thereof |
| 04/09/2008 | CN101156952A DC cell targeted carrier, nanometer corpuscle and preparation method |
| 04/09/2008 | CN100379869C Super antigen fusion protein and its application method |
| 04/09/2008 | CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response |
| 04/09/2008 | CN100379855C Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 04/09/2008 | CN100379759C Compounds for treatment of infectious and immune system disorders and method for their use |
| 04/09/2008 | CN100379758C Streptococcus pneumoniae antigens |
| 04/09/2008 | CN100379752C Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379454C Immunologic adjuvant and vaccine contacning said adjuvant |
| 04/09/2008 | CN100379453C Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection |
| 04/09/2008 | CN100379452C Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 04/09/2008 | CN100379451C 疫苗 Vaccine |
| 04/09/2008 | CN100379450C Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation |
| 04/09/2008 | CN100379349C Method for preparing immune milk anti-pathogenic microoganism in digestive tract |
| 04/08/2008 | US7355027 For inducing an immune response |
| 04/08/2008 | US7355018 human insulin-like growth factor-1 fusion polypeptide that includes a component capable of forming a multimer with another modified IGF-1 fusion polypeptide; useful for treating a muscle-related disease or condition, such as muscle atrophy |
| 04/08/2008 | US7355017 Fusion polypeptide for use in the treatment and prevention of graft rejection |
| 04/08/2008 | US7355016 Methods for detection of mycobacteria |
| 04/08/2008 | US7355011 Comprises chimeric antibodies for diagnosis and treatment of lymphomas; antitumor agents |
| 04/08/2008 | US7354911 1,3-benzodioxol compound and use of same |
| 04/08/2008 | US7354909 Incubating dendritic precursor cells such as monocytes and plasmacytoid dendritic cells with immunostimulatory oligonucleotide to generate antigen presenting cells for use in treatment of cell proliferative disorders; immunotherapy |
| 04/08/2008 | US7354907 immunomer comprising two or more oligonucleotide branches linked together; can cause immune stimulation across species lines; less expensive to make |
| 04/08/2008 | US7354898 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis |
| 04/08/2008 | US7354762 Transfecting with an expression vector containing DNA construct encoding chimeric receptor; electroporation; use in immunotherapy and treatment of neuroblastoma |
| 04/08/2008 | US7354760 Expression of protective antigens in transgenic chloroplasts |
| 04/08/2008 | US7354740 Animal product free system and process for purifying a botulinum toxin |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354714 Production and applications for polyvalent vaccines against diseases caused by papilloma viruses |
| 04/08/2008 | US7354594 Merozoite surface protein 1 lacking glycosylation sites |
| 04/08/2008 | US7354593 Coccidial vaccine and methods of making and using same |
| 04/08/2008 | US7354592 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer |
| 04/08/2008 | US7354591 Poxvirus with targeted infection specificity |
| 04/08/2008 | US7354589 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 04/08/2008 | US7354588 Organ transplantation, tissue grafting, allergy, oncology, diagnosis, therapy |
| 04/08/2008 | US7354587 For inducing humoral and cellular immune responses against malignant cells and infectious agents by intradermally administering a vaccine |
| 04/08/2008 | US7354586 Treating arthritis by administering a therapeutically effective amount of an antibody immunospecific for av beta 3; antiarthritic agents;anticarcinogenic agents; antitumor agents; antimetastasis agents; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3 |
| 04/08/2008 | US7354585 Methods of treating coagulapathic or thrombotic disorders |
| 04/08/2008 | US7354584 Recombinant IL-9 antibodies |
| 04/08/2008 | US7354583 Antibody-induced apoptosis |
| 04/08/2008 | US7354580 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 04/08/2008 | US7354579 Method of treating cancer with a VEGF antagonist and an anti-proliferative agent |
| 04/08/2008 | US7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 04/08/2008 | CA2305013C Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
| 04/08/2008 | CA2122732C Multivalent antigen-binding proteins |
| 04/03/2008 | WO2008040009A1 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation |
| 04/03/2008 | WO2008039974A2 Cancer vaccines and vaccination methods |
| 04/03/2008 | WO2008039969A2 Cancer vaccines and vaccination methods |
| 04/03/2008 | WO2008039876A1 Cytokine signaling |
| 04/03/2008 | WO2008039870A2 Apparatuses, methods and systems for an information comparator preview generator |
| 04/03/2008 | WO2008039761A2 Stabilized antibody formulations and uses thereof |
| 04/03/2008 | WO2008039538A2 Compositions of tlr ligands and antivirals |
| 04/03/2008 | WO2008039432A1 Compositions and methods for enhancing an adjuvant |
| 04/03/2008 | WO2008039408A2 Live bacterial vaccines for viral infection prophylaxis or treatment |
| 04/03/2008 | WO2008039390A2 Compositions and methods for chitosan enhanced immune response |
| 04/03/2008 | WO2008039206A2 Fusion proteins for inhibition and dissolution of coagulation |
| 04/03/2008 | WO2008039200A1 Methods and compositions for treating lymphoma and myeloma |
| 04/03/2008 | WO2008039164A2 Immunogenic compositions comprising anthrax spore-associated proteins |
| 04/03/2008 | WO2008038832A1 Therapeutic agent, detection method and detection kit for breast cancer and ovarian cancer |
| 04/03/2008 | WO2008038394A1 Musclin receptor and use thereof |
| 04/03/2008 | WO2008038127A2 Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| 04/03/2008 | WO2008038002A2 T cell therapies |
| 04/03/2008 | WO2008037996A1 Combination of zd6474 and bevacizumab for cancer therapy |
| 04/03/2008 | WO2008037504A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
| 04/03/2008 | WO2008037419A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | WO2008037257A2 Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors |
| 04/03/2008 | WO2008037225A1 Therapeutic compositions for boosting the effect of antibody therapy against the epidermal growth factor receptor |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2008022302A3 Immunogenic pcpa polypeptides and uses thereof |
| 04/03/2008 | WO2008022298A3 Immunogenic pcpa polypeptides and uses thereof |
| 04/03/2008 | WO2008019379A3 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 04/03/2008 | WO2008019290A3 Human antibodies to erbb 2 |
| 04/03/2008 | WO2008014570A3 Treatment and prevention of allergic airways diseases |
| 04/03/2008 | WO2008014035A3 Modulation of nkg2d and method for treating or preventing solid organ allograft rejection |
| 04/03/2008 | WO2008013454A3 Immunogenic compounds and protein mimics |
| 04/03/2008 | WO2008011201A3 Method of producing meningococcal meningitis vaccine for neisseria meningitidis serotypes a,c,y, and w-135 |
| 04/03/2008 | WO2007146160A3 Methods for the treatment of renal disease using anti-pdgf-dd antibodies |
| 04/03/2008 | WO2007144046A3 Agent for the treatment of malignant diseases |
| 04/03/2008 | WO2007126876A3 Anti-igf-ir antibodies and uses thereof |
| 04/03/2008 | WO2007126799A3 Compositions and methods of use for antibodies of c-met |
| 04/03/2008 | WO2007114851A8 Methods and compositions to induce cell death of invasive tumors |
| 04/03/2008 | WO2007092165A3 Compositions and methods for enhancing neuronal plasticity and regeneration |
| 04/03/2008 | WO2007089582A3 Lipoparticles comprising ion channels, methods of making, and using the same |